Thomas' Hematopoietic Cell Transplantation (3rd edn)

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Transfusion Medicine

• Publication date

  2005-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.0958-7578.2005.00568.X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy

  2016cites this paper
• Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: a comparison of sociodemographic, disease, and treatment characteristics

  2012cites this paper
• Noninvasive liver-iron measurements with a room-temperature susceptometer

  2012influential citation
• Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party

  2011cites this paper
• Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens

  2010cites this paper
• Characterization and management of hypercalcemia following transplantation for osteopetrosis

  2010cites this paper
• How we approach patient evaluation for hematopoietic stem cell transplantation

  2010cites this paper
• Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study

  2010cites this paper
• A retrospective comparison of cyclophosphamide plus antithymocyte globulin with cyclophosphamide plus busulfan as the conditioning regimen for severe aplastic anemia

  2009cites this paper
• Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: alterations and differences of CLA+ T- and NK-cell fractions

  2009cites this paper
• Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience

  2009cites this paper
• Therapy with mycophenolate mofetil for refractory acute and chronic graft-versus-host disease

  2009cites this paper
• Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission

  2009cites this paper
• Multiple BM harvests in pediatric donors for thalassemic siblings: safety, efficacy and ethical issues

  2008cites this paper
• Can etoposide infusion during stem cell transplantation produce a febrile reaction mimicking bacterial sepsis?

  2008cites this paper
• Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease

  2008cites this paper
• Hematopoietic Cell Transplantation Provides an Immune-tolerant Platform for Myoblast Transplantation in Dystrophic Dogs

  2008cites this paper
• Health-related quality of life in survivors of BMT for paediatric malignancy: a systematic review of the literature

  2008cites this paper
• Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants

  2008cites this paper
• Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen

  2008cites this paper
• Allogeneic transplantation for ALL in adults

  2008cites this paper
• Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome

  2007cites this paper
• Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma

  2007cites this paper
• Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant

  2007cites this paper
• Risk assessment in haematopoietic stem cell transplantation: conditioning.

  2007cites this paper
• A case of hepatic graft-versus-host disease complicating autologous stem cell transplantation for relapsed Hodgkin's disease

  2006cites this paper
• Reduced-intensity unrelated cord blood transplantation for treatment of metastatic renal cell carcinoma: first evidence of cord-blood-versus-solid-tumor effect

  2006cites this paper
• Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

  2006cites this paper
• Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease

  2006cites this paper
• Second donation of bone marrow: results from the Japan Marrow Donor Program (JMDP)

  2006cites this paper
• Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome

  2005cites this paper
• ES02.02 
Stem‐cell harvesting and manipulation

  2004cites this paper